Gene program for cardiac cell survival induced by transient ischemia in conscious pigs

Therapy for ischemic heart disease has been directed traditionally at limiting cell necrosis. We determined by genome profiling whether ischemic myocardium can trigger a genetic program promoting cardiac cell survival, which would be a novel and potentially equally important mechanism of salvage. Although cardiac genomics is usually performed in rodents, we used a swine model of ischemia/reperfusion followed by ventricular dysfunction (stunning), which more closely resembles clinical conditions. Gene expression profiles were compared by subtractive hybridization between ischemic and normal tissue of the same hearts. About one-third (23/74) of the nuclear-encoded genes that were up-regulated in ischemic myocardium participate in survival mechanisms (inhibition of apoptosis, cytoprotection, cell growth, and stimulation of translation). The specificity of this response was confirmed by Northern blot and quantitative PCR. Unexpectedly, this program also included genes not previously described in cardiomyocytes. Up-regulation of survival genes was more profound in subendocardium over subepicardium, reflecting that this response in stunned myocardium was proportional to the severity of the ischemic insult. Thus, in a swine model that recapitulates human heart disease, nonlethal ischemia activates a genomic program of cell survival that relates to the time course of myocardial stunning and differs transmurally in relation to ischemic stress, which induced the stunning. Understanding the genes up-regulated during myocardial stunning, including those not previously described in the heart, and developing strategies that activate this program may open new avenues for therapy in ischemic heart disease.

[1]  F. Chen,et al.  The Small Heat Shock Protein αB-Crystallin Negatively Regulates Cytochrome c- and Caspase-8-dependent Activation of Caspase-3 by Inhibiting Its Autoproteolytic Maturation* , 2001, The Journal of Biological Chemistry.

[2]  M. Sherman,et al.  Suppression of Stress Kinase JNK Is Involved in HSP72-mediated Protection of Myogenic Cells from Transient Energy Deprivation , 2000, The Journal of Biological Chemistry.

[3]  R. Bolli.  The Late Phase of Preconditioning , 2000, Circulation research.

[4]  L. Aurelian,et al.  A Novel Human Gene Similar to the Protein Kinase (PK) Coding Domain of the Large Subunit of Herpes Simplex Virus Type 2 Ribonucleotide Reductase (ICP10) Codes for a Serine-Threonine PK and Is Expressed in Melanoma Cells* , 2000, The Journal of Biological Chemistry.

[5]  D M Bers,et al.  Calcium fluxes involved in control of cardiac myocyte contraction. , 2000, Circulation research.

[6]  Dick D. Mosser,et al.  Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome , 2000, Nature Cell Biology.

[7]  E. Rubin,et al.  Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  L. Stanton,et al.  Altered patterns of gene expression in response to myocardial infarction. , 2000, Circulation research.

[9]  Young-Gyu Ko,et al.  Heat Shock Protein 70 Inhibits Apoptosis Downstream of Cytochrome c Release and Upstream of Caspase-3 Activation* , 2000, The Journal of Biological Chemistry.

[10]  P. Declerck,et al.  Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis , 2000, British Journal of Cancer.

[11]  K. Hillan,et al.  Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. , 2000, Circulation.

[12]  M. Kurabayashi,et al.  Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[13]  L. Chalifour,et al.  Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[14]  H. Lodish,et al.  Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Ruiz-Lozano,et al.  Control of segmental expression of the cardiac-restricted ankyrin repeat protein gene by distinct regulatory pathways in murine cardiogenesis. , 1999, Development.

[16]  J. Canty,et al.  Absence of troponin I degradation or altered sarcoplasmic reticulum uptake protein expression after reversible ischemia in swine. , 1999, Circulation research.

[17]  R. Virmani,et al.  Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Ruo-Pan Huang,et al.  p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis , 1999, Oncogene.

[19]  S. Vatner,et al.  Differential regulation of inotropy and lusitropy in overexpressed Gsalpha myocytes through cAMP and Ca2+ channel pathways. , 1999, The Journal of clinical investigation.

[20]  Ruo-Pan Huang,et al.  The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-β1, Fibronectin, and Plasminogen Activator Inhibitor-1* , 1999, The Journal of Biological Chemistry.

[21]  E. Mackenzie,et al.  Up‐regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor β1 , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  G. Shipley,et al.  Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy , 1998, Nature Medicine.

[23]  D. McMillan,et al.  Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. , 1998, Circulation research.

[24]  S. Vatner,et al.  Ineffective perfusion-contraction matching in conscious, chronically instrumented pigs with an extended period of coronary stenosis. , 1998, Circulation research.

[25]  John Calvin Reed,et al.  The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.

[26]  V. Rangnekar,et al.  Role of Egr-1 Gene Expression in B Cell Receptor-induced Apoptosis in an Immature B Cell Lymphoma* , 1997, The Journal of Biological Chemistry.

[27]  M. Malim,et al.  Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Zipfel,et al.  Transcription factor Egr-1 activity down-regulates Fas and CD23 expression in B cells. , 1997, Journal of immunology.

[29]  R. H. Chen,et al.  Involvement of caspase family proteases in transforming growth factor-beta-induced apoptosis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[30]  J. Vanoverschelde,et al.  Chronic myocardial hibernation in humans. From bedside to bench. , 1997, Circulation.

[31]  D. Atar,et al.  Role of troponin I proteolysis in the pathogenesis of stunned myocardium. , 1997, Circulation research.

[32]  Y. Zou,et al.  CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. , 1997, Development.

[33]  K. Schulze-Osthoff,et al.  Small Stress Proteins as Novel Regulators of Apoptosis , 1996, The Journal of Biological Chemistry.

[34]  K. Tamai,et al.  Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes , 1996, Nature.

[35]  J. Dickinson,et al.  Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. , 1995, The Journal of biological chemistry.

[36]  W. Schaper,et al.  Enhanced gene expression of calcium regulatory proteins in stunned porcine myocardium. , 1993, Cardiovascular research.

[37]  R. Bolli.  Myocardial 'stunning' in man. , 1992, Circulation.

[38]  W. Schaper,et al.  Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. , 1992, Circulation research.

[39]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[40]  E. Braunwald,et al.  The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.

[41]  J. Sutko.  Ryanodine Alteration of the Contractile State of Rat Ventricular Myocardium: Comparison with Dog, Cat, and Rabbit Ventricular Tissues , 1980, Circulation research.

[42]  S. Vatner,et al.  Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. , 1975, The Journal of clinical investigation.

[43]  Tsonwin Hai,et al.  ATF3 and stress responses. , 1999, Gene expression.

[44]  Ruo-Pan Huang,et al.  Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation , 1998, Cell Death and Differentiation.

[45]  R. Bolli,et al.  Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. , 1995, The Journal of clinical investigation.